Tuastomban, Mary Cris A.

HRN: 12-94-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/14/2023
06/20/2023
IV
500mg
Q8
Acute Gastroenteritis
Waiting Final Action 
06/14/2023
CEFTRIAXONE 1G (VIAL)
06/14/2023
06/20/2023
IV
2gm
Q24
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: